vs
ICU MEDICAL INC（ICUI）与Rackspace Technology, Inc.（RXT）财务数据对比。点击上方公司名可切换其他公司
Rackspace Technology, Inc.的季度营收约是ICU MEDICAL INC的1.3倍（$682.8M vs $540.7M），ICU MEDICAL INC净利率更高（-2.9% vs -4.8%，领先1.9%），Rackspace Technology, Inc.同比增速更快（-0.4% vs -14.1%），Rackspace Technology, Inc.自由现金流更多（$56.0M vs $36.0M），过去两年Rackspace Technology, Inc.的营收复合增速更高（-0.6% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
Rackspace Technology, Inc.是总部位于美国得克萨斯州圣安东尼奥的云计算企业，在弗吉尼亚州雷斯顿以及澳大利亚、加拿大、英国、印度、迪拜、瑞士、荷兰、德国、新加坡、墨西哥、中国香港等多个国家和地区设有办事处，数据中心分布于全球多个主要城市，为客户提供专业的云计算相关服务。
ICUI vs RXT — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $682.8M |
| 净利润 | $-15.7M | $-32.7M |
| 毛利率 | 37.5% | 17.6% |
| 营业利润率 | 1.0% | -0.5% |
| 净利率 | -2.9% | -4.8% |
| 营收同比 | -14.1% | -0.4% |
| 净利润同比 | 34.0% | 41.6% |
| 每股收益（稀释后） | $-0.63 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $540.7M | $682.8M | ||
| Q3 25 | $537.0M | $671.2M | ||
| Q2 25 | $548.9M | $666.3M | ||
| Q1 25 | $604.7M | $665.4M | ||
| Q4 24 | $629.8M | $685.6M | ||
| Q3 24 | $589.1M | $675.8M | ||
| Q2 24 | $596.5M | $684.9M | ||
| Q1 24 | $566.7M | $690.8M |
| Q4 25 | $-15.7M | $-32.7M | ||
| Q3 25 | $-3.4M | $-67.1M | ||
| Q2 25 | $35.3M | $-54.5M | ||
| Q1 25 | $-15.5M | $-71.5M | ||
| Q4 24 | $-23.8M | $-56.0M | ||
| Q3 24 | $-33.0M | $-186.6M | ||
| Q2 24 | $-21.4M | $25.0M | ||
| Q1 24 | $-39.5M | $-640.6M |
| Q4 25 | 37.5% | 17.6% | ||
| Q3 25 | 37.4% | 19.4% | ||
| Q2 25 | 37.9% | 19.4% | ||
| Q1 25 | 34.7% | 19.1% | ||
| Q4 24 | 36.1% | 19.2% | ||
| Q3 24 | 34.8% | 20.3% | ||
| Q2 24 | 34.8% | 19.2% | ||
| Q1 24 | 32.7% | 19.2% |
| Q4 25 | 1.0% | -0.5% | ||
| Q3 25 | 2.6% | -5.1% | ||
| Q2 25 | 1.9% | -3.8% | ||
| Q1 25 | 2.1% | -5.8% | ||
| Q4 24 | 6.0% | -4.2% | ||
| Q3 24 | 1.4% | -25.7% | ||
| Q2 24 | 1.3% | -7.9% | ||
| Q1 24 | -1.9% | -94.5% |
| Q4 25 | -2.9% | -4.8% | ||
| Q3 25 | -0.6% | -10.0% | ||
| Q2 25 | 6.4% | -8.2% | ||
| Q1 25 | -2.6% | -10.7% | ||
| Q4 24 | -3.8% | -8.2% | ||
| Q3 24 | -5.6% | -27.6% | ||
| Q2 24 | -3.6% | 3.7% | ||
| Q1 24 | -7.0% | -92.7% |
| Q4 25 | $-0.63 | $-0.13 | ||
| Q3 25 | $-0.14 | $-0.28 | ||
| Q2 25 | $1.43 | $-0.23 | ||
| Q1 25 | $-0.63 | $-0.31 | ||
| Q4 24 | $-0.97 | $-0.20 | ||
| Q3 24 | $-1.35 | $-0.82 | ||
| Q2 24 | $-0.88 | $0.11 | ||
| Q1 24 | $-1.63 | $-2.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $105.8M |
| 总债务越低越好 | — | $2.7B |
| 股东权益账面价值 | $2.1B | $-1.2B |
| 总资产 | $4.1B | $2.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $105.8M | ||
| Q3 25 | — | $99.5M | ||
| Q2 25 | — | $103.9M | ||
| Q1 25 | — | $128.0M | ||
| Q4 24 | $308.6M | $144.0M | ||
| Q3 24 | $312.5M | $157.1M | ||
| Q2 24 | $302.6M | $190.2M | ||
| Q1 24 | $251.4M | $282.6M |
| Q4 25 | — | $2.7B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $3.0B |
| Q4 25 | $2.1B | $-1.2B | ||
| Q3 25 | $2.1B | $-1.2B | ||
| Q2 25 | $2.1B | $-1.1B | ||
| Q1 25 | $2.0B | $-1.1B | ||
| Q4 24 | $2.0B | $-1.0B | ||
| Q3 24 | $2.0B | $-949.7M | ||
| Q2 24 | $2.0B | $-756.2M | ||
| Q1 24 | $2.1B | $-787.2M |
| Q4 25 | $4.1B | $2.8B | ||
| Q3 25 | $4.1B | $2.8B | ||
| Q2 25 | $4.1B | $2.9B | ||
| Q1 25 | $4.2B | $3.0B | ||
| Q4 24 | $4.2B | $3.1B | ||
| Q3 24 | $4.3B | $3.1B | ||
| Q2 24 | $4.3B | $3.4B | ||
| Q1 24 | $4.3B | $3.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $59.7M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $56.0M |
| 自由现金流率自由现金流/营收 | 6.6% | 8.2% |
| 资本支出强度资本支出/营收 | 4.6% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.8M | $90.6M |
8季度趋势，按日历期对齐
| Q4 25 | $60.6M | $59.7M | ||
| Q3 25 | $56.7M | $70.7M | ||
| Q2 25 | $11.2M | $8.4M | ||
| Q1 25 | $51.3M | $12.6M | ||
| Q4 24 | $40.2M | $54.3M | ||
| Q3 24 | $36.1M | $51.8M | ||
| Q2 24 | $82.0M | $24.1M | ||
| Q1 24 | $45.8M | $-90.3M |
| Q4 25 | $36.0M | $56.0M | ||
| Q3 25 | $27.6M | $42.7M | ||
| Q2 25 | $-8.5M | $-12.4M | ||
| Q1 25 | $36.7M | $4.3M | ||
| Q4 24 | $16.1M | $34.4M | ||
| Q3 24 | $16.2M | $27.3M | ||
| Q2 24 | $62.5M | $-14.5M | ||
| Q1 24 | $29.9M | $-118.4M |
| Q4 25 | 6.6% | 8.2% | ||
| Q3 25 | 5.1% | 6.4% | ||
| Q2 25 | -1.5% | -1.9% | ||
| Q1 25 | 6.1% | 0.6% | ||
| Q4 24 | 2.6% | 5.0% | ||
| Q3 24 | 2.7% | 4.0% | ||
| Q2 24 | 10.5% | -2.1% | ||
| Q1 24 | 5.3% | -17.1% |
| Q4 25 | 4.6% | 0.5% | ||
| Q3 25 | 5.4% | 4.2% | ||
| Q2 25 | 3.6% | 3.1% | ||
| Q1 25 | 2.4% | 1.2% | ||
| Q4 24 | 3.8% | 2.9% | ||
| Q3 24 | 3.4% | 3.6% | ||
| Q2 24 | 3.3% | 5.6% | ||
| Q1 24 | 2.8% | 4.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.96× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
RXT
| Public Cloud Services Segment | $442.2M | 65% |
| Private Cloud Service Segment | $240.6M | 35% |
